When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

The Business Journals

United States

Takeda’s next CEO is a familiar face in Massachusetts biotech scene

Ad Fontes Media

All Sides

Media Bias/Fact Check

Advance Publications

OSAKA, Japan & CAMBRIDGE, Mass. -- Takeda ( TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Mr. Weber retires from the company in June 2026. Mrs. Kim will be proposed as a candidate for election to the Boar…

Financial Post

Leon Cooperman

Allianz

Canada

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. bu

Nikkei

Nikkei, Inc.

Japan

Japan's Takeda names 1st female CEO in leadership change

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who plans to retire in June next year.

BizToc

Takeda Pharmaceutical Raises Earnings Guidance, Names Julie Kim as New CEO

Julie Kim, currently president of Takeda’s U.S. business unit, will succeed him, making her one of the few female chief executives in the pharma industry.

STAT

The Boston Globe

Boston

Suffolk County

Massachusetts

Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Osaka, Japan & Cambridge, Mass., United States:
  
CEO Christophe Weber to retire from Takeda in June 2026 after 12 years 
Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process 
Takeda (TOKYO:4502/NYSE:TAK) announced today that its board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Tak…

Businessfortnight

Latest News Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026 - Businessfortnight

Julie Kim to succeed Christophe Weber as Takeda CEO in 2026, marking a historic transition as the company prepares for new product launches and continued growth trajectory.

stocktitan.net

Historic First: Meet the Woman Breaking Japan's Pharma Glass Ceiling at Takeda

Takeda CEO Christophe Weber will step down next June after more than 10 years leading the Japanese drugmaker.
Julie Kim, the current president of Takeda’s US business unit, will succeed Weber in June 2026 and ...

Endpoints News

Takeda CEO Christophe Weber to retire in June 2026, Julie Kim to take over

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.

Pharmaphorum

Takeda CEO succession confirmed as Weber plans retirement

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

Takeda’s next CEO is a familiar face in Massachusetts biotech scene

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics